EMA QA Document for the Implementation of the Variations Guidelines
The European Medicines Agency (EMA) has published a document with practical questions and answers to support the implementation of the variations guidelines in the centralised procedure. The Q&A Document provides practical considerations concerning the implementation of the various categories of variations, on the operation of the respective procedures and on the documentation to be submitted pursuant to those procedures (the 'variations guidelines')
The questions are organised into the following themes:
- general consideration
- new classification category C.1.11
- new classification category C.1.13
- impact on post-authorisation measure (PAM) submissions
- revised classification category C.I.8
- new classification category A.8
Source: EMA/427505/2013 Rev.1
Related GMP News
22.10.2025Content Review of the Audit Trail Review
15.10.2025Executing the Audit Trail Review
08.10.2025Risk-based Determination of the Scope and Frequency of Audit Trail Reviews
01.10.2025Decentralised Manufacturing: New UK Framework in Operation
24.09.2025Responsibilities for the Audit Trail (Review)
17.09.2025When Training Falls Short: FDA Findings on GMP Training Deficiencies in 2025




